Amanote Research

Amanote Research

    RegisterSign In

Symptomatic Therapy in Multiple Sclerosis

Therapeutic Advances in Neurological Disorders - United Kingdom
doi 10.1177/1756285611400658
Full Text
Open PDF
Abstract

Available in full text

Categories
NeurologyPharmacology
Date

March 1, 2011

Authors
Teresa C. FrohmanWanda CastroAnjali ShahArdith CourtneyJeffrey OrtstadtScott L. DavisDiana LoganThomas AbrahamJaspreet AbrahamGina RemingtonKatherine TreadawayDonna GravesJohn HartOlaf StuveGary LemackBenjamin GreenbergElliot M. Frohman
Publisher

SAGE Publications


Related search

Cyclophosphamide Therapy in Pediatric Multiple Sclerosis

Neurology
Neurology
2009English

Symptomatic Narcolepsy in Patients With Neuromyelitis Optica and Multiple Sclerosis

Archives of Neurology
2009English

Laquinimod Therapy in Multiple Sclerosis: A Comprehensive Review

Neurology and Therapy
Neurology
2014English

Cytoflavin in the Complex Therapy of Multiple Sclerosis

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
PsychiatryMental HealthNeurology
2018English

Stem Cell Therapy in Patients With Multiple Sclerosis

Multiple Sclerosis
Neurology
2006English

Multiple Sclerosis Disease-Modifying Therapy and Pregnancy

Multiple Sclerosis
Neurology
2016English

PND3 Risk-Benefit Analysis of Therapy in Multiple Sclerosis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Vitamin D Role in Multiple Sclerosis Etiology and Therapy

Medicinski Casopis
Medicine
2018English

Natalizumab Therapy for Highly Active Pediatric Multiple Sclerosis

JAMA Neurology
Neurology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy